National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2012 (No. 1)
National Health Act 1953
___________________________________________________________________________
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this instrument under subsections 100(1) and (2) of the National Health Act 1953.
Dated 16 February 2012
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
___________________________________________________________________
1 Name of Instrument
(1) This Instrument is the National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2012 (No. 1).
(2) This Instrument may also be cited as PB 4 of 2012.
2 Commencement
This Instrument commences on 1 March 2012.
3 Amendments to PB 79 of 2011
Schedule 1 amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011).
Schedule 1 Amendments
[1] Schedule 1 Part 1, entry for Epirubicin in the form Solution for injection containing epirubicin hydrochloride 10 mg in 5 mL with manner of administration Injection/intravesical and brand Epirubicin Ebewe
substitute:
Epirubicin | Solution for injection containing epirubicin hydrochloride 10 mg in 5 mL | Injection/ intravesical | Epirubicin Actavis 10 | TA | MP |
| D |
|
|
| Epirubicin Ebewe | SZ | MP |
| D |
[2] Schedule 1 Part 1, entry for Epirubicin in the form Solution for injection containing epirubicin hydrochloride 100 mg in 50 mL with manner of administration Injection/intravesical and brand Epirubicin Ebewe
substitute:
| Solution for injection containing epirubicin hydrochloride 100 mg in 50 mL | Injection/ intravesical | Epirubicin Actavis 100 | TA | MP |
| D |
|
|
| Epirubicin Ebewe | SZ | MP |
| D |
[3] Schedule 1 Part 1, entry for Epirubicin in the form Solution for injection containing epirubicin hydrochloride 20 mg in 10 mL with manner of administration Injection/intravesical and brand Pharmorubicin Solution
substitute:
| Solution for injection containing epirubicin hydrochloride 20 mg in 10 mL | Injection/ intravesical | Epirubicin Actavis 20 | TA | MP |
| D |
|
|
| Pharmorubicin Solution | PF | MP |
| D |
[4] Schedule 1 Part 1, after entry for Epirubicin in the form Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL with manner of administration Injection/intravesical and brand DBL Epirubicin Hydrochloride Injection
insert in the columns in the order indicated:
|
|
| Epirubicin Actavis 200 | TA | MP |
| D |
[5] Schedule 1 Part 1, entry for Epirubicin in the form Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL with manner of administration Injection/intravesical and brand Epirubicin Ebewe
substitute:
| Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL | Injection/ intravesical | Epirubicin Actavis 50 | TA | MP |
| D |
|
|
| Epirubicin Ebewe | SZ | MP |
| D |
[6] Schedule 1 Part 1, entry for Gemcitabine
omit from the column headed “Circumstances” (all instances):
C1193 | C1194 |
C1740 | C2069 |
C2141 | C3889 |
C3890 | C3906 |
C3913 | C3914 |
[7] Schedule 1 Part 1, after entry for Gemcitabine in the form Powder for I.V. infusion 200 mg (as hydrochloride) with manner of administration Injection and brand Gemzar
insert in the columns in the order indicated:
| Solution concentrate for I.V. infusion 1 g (as hydrochloride) in 25 mL | Injection | Gemcitabine Ebewe | SZ | MP |
| D |
[8] Schedule 1 Part 1, after entry for Gemcitabine in the form Solution concentrate for I.V. infusion 1000 mg (as hydrochloride) in 100 mL
insert in the columns in the order indicated:
| Solution concentrate for I.V. infusion 2 g (as hydrochloride) in 50 mL | Injection | Gemcitabine Ebewe | SZ | MP |
| D |
[9] Schedule 1 Part 1, after entry for Gemcitabine in the form Solution concentrate for I.V. infusion 200 mg (as hydrochloride) in 20 mL
insert in the columns in the order indicated:
| Solution concentrate for I.V. infusion 200 mg (as hydrochloride) in 5 mL | Injection | Gemcitabine Ebewe | SZ | MP |
| D |
[10] Schedule 4, omit entry for Gemcitabine
Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.